trending Market Intelligence /marketintelligence/en/news-insights/trending/Z0ovWqb7Oji1AT749kfznw2 content esgSubNav
In This List

Suda proposes 25-to-1 share consolidation to address price volatility

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Suda proposes 25-to-1 share consolidation to address price volatility

Suda Pharmaceuticals Ltd. is proposing a 25-to-1 consolidation of its shares to mitigate certain share price issues.

If shareholders approve the consolidation at the company's general meeting on Nov. 12, the issued shares in Suda will decrease to about 142 million shares from about 3.6 billion shares. Following approval, options will also be reorganized and consolidated in the same ratio.

The exercise price of the options will also be adjusted in inverse proportion to the consolidation's ratio.

Suda Pharmaceuticals is a drug delivery company focusing on oro-mucosal administration.